Migraine Trial, Recruiting NCT06309251 Sponsor: Danone Nutricia SpA Società Benefit Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT06309251
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children under 18 years old who have epilepsy that has not been controlled by at least two different seizure medications, and who are being treated with a ketogenic diet (a special high-fat, low-carbohydrate diet)
  • Children under 18 years old who have a genetic, metabolic, or neurological condition (whether present from birth or developed later) and are being treated with a ketogenic diet, even if they do not have epilepsy — this includes newer uses of the ketogenic diet or its use in intensive care settings for severe, prolonged seizures

Who may not be able to join:

  • Children who have certain conditions affecting how the body processes fats, carnitine, or energy, including: beta-oxidation cycle disorders, primary carnitine deficiency, primary dyslipidemia, pyruvate carboxylase deficiency, porphyria, mitochondrial disease, problems with how the body makes or breaks down ketones, or problems with the body's process of making glucose
  • Children who have type 1 diabetes
  • Children whose parents or caregivers are not able to reliably follow the requirements of the diet and study (confirm with trial site for full details of this criterion)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 06 6859 2189

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Danone Nutricia SpA Società Benefit
Registry
ClinicalTrials.gov
Start date
1 March 2022
Est. completion
31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Nutritional adequacy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov